Surgical Glue Market Size, Trends and Insights By Type (Natural, Synthetic), By Application (Nervous System Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, Others), By End User (Hospitals, Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Ethicon Inc.
- Baxter International Inc.
- Medtronic plc
- Braun Melsungen AG
- 3M Company
- CryoLife Inc.
- Others
Reports Description
Global Surgical Glue Market was valued at USD 3.8 Billion in 2024 and is expected to reach USD 11.4 Billion by 2033, at a CAGR of 7.1% during the forecast period 2024 – 2033.
Surgical glue, also known as tissue adhesive used in surgical procedures to seal wounds, incisions, or lacerations. It is applied topically to the skin or tissues and forms a bond that helps hold the wound edges together, promoting healing and reducing the risk of infection. Surgical glue is commonly used as an alternative to traditional sutures or staples, particularly for smaller wounds or in areas where sutures may be impractical or cosmetically undesirable.
Surgical Glue Market: Growth Factors
Increase in the incidence of wounds and injuries
The increase in the incidence of wounds and injuries is a significant driver for the surgical glue market for several reasons. Firstly, as the population grows and ages, there is a higher likelihood of accidents, falls, and injuries, leading to more wounds that require medical attention.
Additionally, lifestyle factors such as sports activities and outdoor recreation contribute to the risk of cuts, abrasions, and other types of trauma. Moreover, the rising prevalence of chronic diseases such as diabetes, which can lead to complications like diabetic ulcers, further contributes to the demand for wound closure solutions.
Surgical glue offers several advantages in these scenarios, including faster application, reduced risk of infection, minimal scarring, and improved patient comfort compared to traditional sutures or staples. Furthermore, the increasing adoption of surgical glue by healthcare providers is driven by advancements in adhesive technology, leading to products with enhanced strength, flexibility, and biocompatibility.
These factors combined propel the growth of the surgical glue market as healthcare facilities seek efficient and effective solutions for wound closure to meet the growing demand. For instance, as reported by the National Institute of Diabetes and Digestive and Kidney Diseases in the United States, open wounds affect approximately 3% of individuals aged 65 and above. Government projections indicate that by 2060, the elderly population will exceed 77 million, underscoring the ongoing challenge of chronic wounds within this demographic.
Rising popularity of plastic surgeries drives market growth
The increasing popularity of plastic surgeries significantly drives the surgical glue market for several reasons. Firstly, plastic surgeries often involve delicate procedures that require precise wound closure techniques to achieve optimal aesthetic outcomes.
Surgical glue provides an alternative to traditional sutures or staples, offering a more cosmetically appealing option for patients undergoing procedures such as facelifts, breast augmentation, or rhinoplasty. Moreover, surgical glue simplifies wound closure, reducing procedure time and postoperative discomfort for patients. Its ease of use and non-invasive application make it particularly attractive for minimally invasive cosmetic procedures.
Additionally, as plastic surgery becomes more mainstream and socially acceptable, the demand for advanced wound closure solutions continues to rise. Surgeons and patients alike are increasingly seeking innovative products that enhance surgical outcomes and patient satisfaction, thereby fuelling the growth of the surgical glue market within the plastic surgery sector.
For instance, the British Association of Aesthetic Plastic Surgeons (BAAPS) (UK) published its yearly audit, revealing that in 2022, there were 31,057 cosmetic procedures performed, marking a 102% increase from the previous year. Women accounted for 93% of all cosmetic procedures in 2022, indicating a 101% rise compared to 2021.
Surgical Glue Market: Restraints
High cost of surgical glue presents a significant barrier
The high cost of surgical glue presents a significant barrier to its widespread adoption and growth in the surgical glue market. Healthcare facilities, particularly in resource-limited settings or regions with constrained healthcare budgets, may find the expense prohibitive, limiting their ability to purchase and utilize surgical glue routinely.
Additionally, patients may face higher out-of-pocket expenses or insurance co-payments for procedures involving surgical glue, potentially deterring them from opting for this treatment option. Moreover, healthcare providers may be hesitant to incorporate surgical glue into their practice if the cost outweighs perceived benefits, such as reduced procedure time or improved cosmetic outcomes.
Addressing the cost challenge through price reductions, reimbursement adjustments, or the development of more cost-effective formulations could help expand access to surgical glue and drive market growth by making it a more viable option for a broader range of healthcare settings and patient populations.
Surgical Glue Market: Opportunities
Recent developments of synthetic glues
Recent advancements in synthetic glues have propelled the surgical glue market forward by offering enhanced properties and versatility in wound closure applications. These synthetic glues, often based on cyanoacrylate or other biocompatible polymers, provide several advantages over traditional sutures and staples. They offer quick adhesion, minimizing procedure time and reducing patient discomfort.
These innovations have expanded the range of surgical procedures where glue can be used effectively, including minimally invasive surgeries and delicate tissue repairs. Overall, the evolution of synthetic glue continues to drive growth in the surgical glue market by offering surgeons and patients more efficient, effective, and convenient wound closure solutions.
For instance, in recent years, there has been a development of polymer-based tissue adhesives (TAs) as a substitute for sutures in closing and sealing incisions or wounds. This is due to their user-friendly nature, quick application, affordability, and minimal impact on tissues.
Surgical Glue Market: Segmentation Analysis
The surgical Glue market is segmented by type, application, end user and region. Based on type, the market is classified into natural and synthetic. Synthetic glues dominated the market in 2022 with a market share of 60% and are expected to keep their dominance during the forecast period 2024-2032.
Synthetic glues play a significant role in driving the surgical glue market due to their advantageous properties compared to traditional alternatives. Synthetic glues offer greater flexibility, adhesion strength, and biocompatibility, making them ideal for medical applications such as wound closure. These glues are often formulated to be biodegradable or bioabsorbable, ensuring they degrade harmlessly within the body over time.
Additionally, synthetic glues can be tailored to specific medical requirements, such as providing antibacterial properties or promoting tissue regeneration. As a result, the demand for surgical glues derived from synthetic formulations continues to grow, driving innovation and expansion in the surgical glue market.
Based on application, the market is classified into central nervous system surgeries, general surgeries, cardiovascular surgeries, orthopaedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries and others.
The cardiovascular surgeries segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032. Surgical glues provide an alternative or adjunct to sutures and staples, offering quick and reliable sealing of incisions, reducing operative time, and improving patient outcomes.
Moreover, as cardiovascular surgeries continue to advance with minimally invasive techniques, there is a growing need for specialized adhesives that can effectively seal access sites and repair vascular and cardiac defects without the need for large incisions.
Based on end user, the market is classified into hospitals, clinics, and others. The hospital segment dominated the market in 2022 with a market share of 65% and is expected to keep its dominance during the forecast period 2024-2032. Hospitals are major consumers of surgical glue, using it extensively in various surgical procedures to close wounds, incisions, and lacerations.
As hospitals strive for improved patient outcomes, they increasingly adopt surgical glue due to its effectiveness in wound closure, reduced healing time, and minimized scarring compared to traditional sutures or staples.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 3.8 Billion |
| Projected Market Size in 2033 | USD 11.4 Billion |
| Market Size in 2023 | USD 3.5 Billion |
| CAGR Growth Rate | 7.1% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Surgical Glue Market: Regional Analysis
By region, Surgical Glue market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. North America dominated the global Surgical Glue market in 2022 with a market share of 40% in 2022 and is expected to keep its dominance during the forecast period 2024-2032. North America drives the surgical glue market due to several factors.
The region boasts advanced healthcare infrastructure and significant investments in medical research and development, fostering the adoption of innovative medical technologies such as surgical glue. Additionally, the high prevalence of chronic diseases, injuries, and surgeries in North America increases the demand for wound closure products, including surgical glue.
Furthermore, rising healthcare expenditures and insurance coverage encourage patients to seek advanced wound closure methods, further propelling the market growth. Moreover, the region’s aging population and increasing preference for minimally invasive surgical procedures contribute to the growing demand for surgical glue as a convenient and effective alternative to sutures or staples.
Overall, North America’s robust healthcare system, coupled with demographic and socioeconomic factors, positions it as a key driver of the surgical glue market.
Surgical Glue Market: Recent Developments
- In March 2023, Johnson & Johnson launched DERMABOND ADVANCED™ adhesive is designed solely for topical application to securely close the easily approximated skin edges of wounds resulting from surgical incisions, including those from minimally invasive surgery.
- In May 2023, Medtronic launched SwiftSet™ butyl cyanoacrylate topical skin adhesive with a 30-second dry time.
- In October 2021, Cardinal Health introduced its SecureSeal Octyl Topical Skin Adhesive, now available for use alongside deep dermal stitches. This adhesive offers a microbial barrier, safeguarding wounds by sealing out bacteria that could lead to infection.
List of the prominent players in the Surgical Glue Market:
- Ethicon Inc.
- Baxter International Inc.
- Medtronic plc
- Braun Melsungen AG
- 3M Company
- CryoLife Inc.
- Cardinal Health Inc.
- Cohera Medical Inc.
- Takeda Pharmaceutical Company Limited
- Chemence Medical Inc.
- Integra LifeSciences Corporation
- Advanced Medical Solutions Group plc
- Meyer-Haake GmbH Medical Innovations
- Adhezion Biomedical LLC
- GluStitch Inc.
- HyperBranch Medical Technology Inc.
- Johnson & Johnson Services Inc.
- Tissuemed Ltd.
- Luna Innovations Incorporated
- R. Bard Inc.
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Surgical Glue Market is segmented as follows:
By Type
- Natural
- Synthetic
By Application
- Nervous System Surgeries
- General Surgeries
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Cosmetic Surgeries
- Ophthalmic Surgeries
- Urological Surgeries
- Pulmonary Surgeries
- Others
By End User
- Hospitals
- Clinics
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Surgical Glue Market, (2024 – 2033) (USD Billion)
- 2.2 Global Surgical Glue Market: snapshot
- Chapter 3. Global Surgical Glue Market – Industry Analysis
- 3.1 Surgical Glue Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase in the incidence of wounds and injuries
- 3.2.2 Rising popularity of plastic surgeries drives market growth
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Surgical Glue Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Surgical Glue Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Surgical Glue Market – Type Analysis
- 5.1 Global Surgical Glue Market Overview: By Type
- 5.1.1 Global Surgical Glue Market Share, By Type, 2023 and 2033
- 5.2 Natural
- 5.2.1 Global Surgical Glue Market by Natural, 2024 – 2033 (USD Billion)
- 5.3 Synthetic
- 5.3.1 Global Surgical Glue Market by Synthetic, 2024 – 2033 (USD Billion)
- 5.1 Global Surgical Glue Market Overview: By Type
- Chapter 6. Global Surgical Glue Market – Application Analysis
- 6.1 Global Surgical Glue Market Overview: By Application
- 6.1.1 Global Surgical Glue Market Share, By Application, 2023 and 2033
- 6.2 Nervous System Surgeries
- 6.2.1 Global Surgical Glue Market by Nervous System Surgeries, 2024 – 2033 (USD Billion)
- 6.3 General Surgeries
- 6.3.1 Global Surgical Glue Market by General Surgeries, 2024 – 2033 (USD Billion)
- 6.4 Cardiovascular Surgeries
- 6.4.1 Global Surgical Glue Market by Cardiovascular Surgeries, 2024 – 2033 (USD Billion)
- 6.5 Orthopedic Surgeries
- 6.5.1 Global Surgical Glue Market by Orthopedic Surgeries, 2024 – 2033 (USD Billion)
- 6.6 Cosmetic Surgeries
- 6.6.1 Global Surgical Glue Market by Cosmetic Surgeries, 2024 – 2033 (USD Billion)
- 6.7 Ophthalmic Surgeries
- 6.7.1 Global Surgical Glue Market by Ophthalmic Surgeries, 2024 – 2033 (USD Billion)
- 6.8 Urological Surgeries
- 6.8.1 Global Surgical Glue Market by Urological Surgeries, 2024 – 2033 (USD Billion)
- 6.9 Pulmonary Surgeries
- 6.9.1 Global Surgical Glue Market by Pulmonary Surgeries, 2024 – 2033 (USD Billion)
- 6.10 Others
- 6.10.1 Global Surgical Glue Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global Surgical Glue Market Overview: By Application
- Chapter 7. Global Surgical Glue Market – End User Analysis
- 7.1 Global Surgical Glue Market Overview: By End User
- 7.1.1 Global Surgical Glue Market Share, By End User, 2023 and 2033
- 7.2 Hospitals
- 7.2.1 Global Surgical Glue Market by Hospitals, 2024 – 2033 (USD Billion)
- 7.3 Clinics
- 7.3.1 Global Surgical Glue Market by Clinics, 2024 – 2033 (USD Billion)
- 7.4 Others
- 7.4.1 Global Surgical Glue Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global Surgical Glue Market Overview: By End User
- Chapter 8. Surgical’s Glue Market – Regional Analysis
- 8.1 Global Surgical’s Glue Market Regional Overview
- 8.2 Global Surgical’s Glue Market Share, by Region, 2023 & 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Surgical’s Glue Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.4 North America Surgical’s Glue Market, by Type, 2024 – 2033
- 8.4.1 North America Surgical’s Glue Market, by Type, 2024 – 2033 (USD Billion)
- 8.5 North America Surgical’s Glue Market, by Application, 2024 – 2033
- 8.5.1 North America Surgical’s Glue Market, by Application, 2024 – 2033 (USD Billion)
- 8.6 North America Surgical’s Glue Market, by End User, 2024 – 2033
- 8.6.1 North America Surgical’s Glue Market, by End User, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Surgical’s Glue Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Surgical’s Glue Market, by Type, 2024 – 2033
- 8.8.1 Europe Surgical’s Glue Market, by Type, 2024 – 2033 (USD Billion)
- 8.9 Europe Surgical’s Glue Market, by Application, 2024 – 2033
- 8.9.1 Europe Surgical’s Glue Market, by Application, 2024 – 2033 (USD Billion)
- 8.10 Europe Surgical’s Glue Market, by End User, 2024 – 2033
- 8.10.1 Europe Surgical’s Glue Market, by End User, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Surgical’s Glue Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Surgical’s Glue Market, by Type, 2024 – 2033
- 8.12.1 Asia Pacific Surgical’s Glue Market, by Type, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Surgical’s Glue Market, by Application, 2024 – 2033
- 8.13.1 Asia Pacific Surgical’s Glue Market, by Application, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Surgical’s Glue Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Surgical’s Glue Market, by End User, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Surgical’s Glue Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Surgical’s Glue Market, by Type, 2024 – 2033
- 8.16.1 Latin America Surgical’s Glue Market, by Type, 2024 – 2033 (USD Billion)
- 8.17 Latin America Surgical’s Glue Market, by Application, 2024 – 2033
- 8.17.1 Latin America Surgical’s Glue Market, by Application, 2024 – 2033 (USD Billion)
- 8.18 Latin America Surgical’s Glue Market, by End User, 2024 – 2033
- 8.18.1 Latin America Surgical’s Glue Market, by End User, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Surgical’s Glue Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Surgical’s Glue Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Surgical’s Glue Market, by Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa Surgical’s Glue Market, by Type, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Surgical’s Glue Market, by Application, 2024 – 2033
- 8.21.1 The Middle-East and Africa Surgical’s Glue Market, by Application, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Surgical’s Glue Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Surgical’s Glue Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Ethicon Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Baxter International Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Medtronic plc
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 B. Braun Melsungen AG
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 3M Company
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 CryoLife Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Cardinal Health Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Cohera Medical Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Takeda Pharmaceutical Company Limited
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Chemence Medical Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Integra LifeSciences Corporation
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Advanced Medical Solutions Group plc
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Meyer-Haake GmbH Medical Innovations
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Adhezion Biomedical LLC
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 GluStitch Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 HyperBranch Medical Technology Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Johnson & Johnson Services Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Tissuemed Ltd.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Luna Innovations Incorporated
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 C.R. Bard Inc.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Ethicon Inc.
List Of Figures
Figures No 1 to 30
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Ethicon Inc.
- Baxter International Inc.
- Medtronic plc
- Braun Melsungen AG
- 3M Company
- CryoLife Inc.
- Cardinal Health Inc.
- Cohera Medical Inc.
- Takeda Pharmaceutical Company Limited
- Chemence Medical Inc.
- Integra LifeSciences Corporation
- Advanced Medical Solutions Group plc
- Meyer-Haake GmbH Medical Innovations
- Adhezion Biomedical LLC
- GluStitch Inc.
- HyperBranch Medical Technology Inc.
- Johnson & Johnson Services Inc.
- Tissuemed Ltd.
- Luna Innovations Incorporated
- R. Bard Inc.
- Others
FAQs
The restraints of the Surgical Glue market is high cost of surgical glue.
The major driver for the Surgical Glue market is increase in the incidence of wounds and injuries and rising popularity of plastic surgeries.
The “Natural” category dominated the market in 2023.
The key players in the market are Ethicon Inc., Baxter International Inc., Medtronic plc, B. Braun Melsungen AG, 3M Company, CryoLife Inc., Cardinal Health Inc., Cohera Medical Inc., Takeda Pharmaceutical Company Limited, Chemence Medical Inc., Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Meyer-Haake GmbH Medical Innovations, Adhezion Biomedical LLC, GluStitch Inc., HyperBranch Medical Technology Inc., Johnson & Johnson Services Inc., Tissuemed Ltd., Luna Innovations Incorporated, C.R. Bard Inc., Others.
“North America” had the largest share in the Surgical Glue Market.
The global market is projected to grow at a CAGR of 7.1% during the forecast period, 2024-2033.
The Surgical Glue Market size was valued at USD 3.8 Billion in 2024.